SELLAS Life Sciences Group, Inc.
Ticker: 1390478
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY22 | Q1 FY22 | Q2 FY21 | Q2 FY21 | Q1 FY21 |
|---|---|---|---|---|---|
| INCOME | |||||
| Revenue | 1.00+0.0% | 1.00-47.4% | 1.90+0.0% | 1.90-66.7% | 5.70 |
| Total Income | 1.00+0.0% | 1.00-47.4% | 1.90+0.0% | 1.90-66.7% | 5.70 |
| EXPENSES | |||||
| Expenditure | 17.74+0.0% | 17.74+179.4% | 6.35+0.0% | 6.35-20.1% | 7.95 |
| PROFIT | |||||
| Net Profit | -16.74+0.0% | -16.74-263.1% | -4.61+0.0% | -4.61-92.1% | -2.40 |
| KEY METRICS | |||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00%-60.61pp | -39.39% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00%-57.84pp | -42.16% |
| EPS | -1.05+0.0% | -1.05-250.0% | -0.30+0.0% | -0.30 | — |
Corporate Events
Board MeetingSLS
202624Jun
Board Meeting
Amendments to compensatory arrangements for Dr. Angelos Ster…
SEC Filing ↗ Board MeetingSLS
202616Jun
Board Meeting
Results of the Annual Meeting of Stockholders, including the…
SEC Filing ↗